144 related articles for article (PubMed ID: 38413247)
21. Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34
Scordo M; Shah GL; Kosuri S; Herrera DA; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Avecilla ST; Meagher RC; Carlow DC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Tamari R; Perales MA; Giralt SA; Shaffer BC
Biol Blood Marrow Transplant; 2018 Jan; 24(1):133-141. PubMed ID: 28870777
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Buckley RH; Puck J; Fleisher TA; Gennery AR; Haddad E; Neven B; Slatter M; Roderick S; Baker KS; Dietz AC; Duncan C; Griffith LM; Notarangelo L; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1229-1240. PubMed ID: 28479164
[TBL] [Abstract][Full Text] [Related]
23. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
Saunders IM; Tan M; Koura D; Young R
Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
[TBL] [Abstract][Full Text] [Related]
24. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
[TBL] [Abstract][Full Text] [Related]
25. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
26. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
[TBL] [Abstract][Full Text] [Related]
27. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.
Dietz AC; Duncan CN; Alter BP; Bresters D; Cowan MJ; Notarangelo L; Rosenberg PS; Shenoy S; Skinner R; Walters MC; Wagner J; Baker KS; Pulsipher MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):24-29. PubMed ID: 27737772
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation.
Baker KS; Chow E; Steinberger J
Bone Marrow Transplant; 2012 May; 47(5):619-25. PubMed ID: 21643022
[TBL] [Abstract][Full Text] [Related]
29. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
[TBL] [Abstract][Full Text] [Related]
30. Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection among Adult Long-Term Hematopoietic Cell Transplantation Survivors.
Liang EC; Onstad LE; Carpenter P; Pergam SA; Flowers ME; Lee SJ; Liu C
Transplant Cell Ther; 2023 Sep; 29(9):584.e1-584.e9. PubMed ID: 37394113
[TBL] [Abstract][Full Text] [Related]
31. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
[TBL] [Abstract][Full Text] [Related]
32. Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.
Hashmi S; Carpenter P; Khera N; Tichelli A; Savani BN
Biol Blood Marrow Transplant; 2015 Feb; 21(2):225-32. PubMed ID: 24999225
[TBL] [Abstract][Full Text] [Related]
33. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
34. Conditional Survival, Cause-Specific Mortality, and Risk Factors of Late Mortality After Allogeneic Hematopoietic Cell Transplantation.
Wong FL; Teh JB; Atencio L; Stiller T; Kim H; Chanson D; Forman SJ; Nakamura R; Armenian SH
J Natl Cancer Inst; 2020 Nov; 112(11):1153-1161. PubMed ID: 32044955
[TBL] [Abstract][Full Text] [Related]
35. Late-occurring infections in a contemporary cohort of hematopoietic cell transplantation survivors.
Sy A; Chanson D; Berano Teh J; Wong FL; Nakamura R; Dadwal S; Armenian SH
Cancer Med; 2021 May; 10(9):2956-2966. PubMed ID: 33835722
[TBL] [Abstract][Full Text] [Related]
36. Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan.
Kurosawa S; Mori A; Tsukagoshi M; Onishi Y; Ohwada C; Mori T; Goto H; Asano-Mori Y; Nawa Y; Hino M; Fukuchi T; Mori Y; Yamahana R; Inamoto Y; Fukuda T
Biol Blood Marrow Transplant; 2020 May; 26(5):949-955. PubMed ID: 31962164
[TBL] [Abstract][Full Text] [Related]
37. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation.
Atsuta Y; Hirakawa A; Nakasone H; Kurosawa S; Oshima K; Sakai R; Ohashi K; Takahashi S; Mori T; Ozawa Y; Fukuda T; Kanamori H; Morishima Y; Kato K; Yabe H; Sakamaki H; Taniguchi S; Yamashita T;
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1702-1709. PubMed ID: 27246369
[TBL] [Abstract][Full Text] [Related]
38. Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial Survey.
Salit RB; Lee SJ; Burns LJ; Shaw BE; Majhail NS; Bhatt NS; Wood WA; Syrjala KL
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1520-1526. PubMed ID: 32360563
[TBL] [Abstract][Full Text] [Related]
39. Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Bar M; Ott SM; Lewiecki EM; Sarafoglou K; Wu JY; Thompson MJ; Vaux JJ; Dean DR; Saag KG; Hashmi SK; Inamoto Y; Dholaria BR; Kharfan-Dabaja MA; Nagler A; Rodriguez C; Hamilton BK; Shah N; Flowers MED; Savani BN; Carpenter PA
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1784-1802. PubMed ID: 32653624
[TBL] [Abstract][Full Text] [Related]
40. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N; Weaver MT; Al-Mansour Z; Yi JC; Jim HSL; Loren AW; Majhail NS; Whalen V; Uberti J; Wingard JR; Lynch Kelly D; Syrjala KL
Transplant Cell Ther; 2022 Sep; 28(9):606.e1-606.e8. PubMed ID: 35662590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
